Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Van Woert

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
The New England Journal of Medicine|April 20, 1978
Profitable and nonprofitable drugsM H Van Woert
Clinical Pharmacology and Therapeutics|March 1, 1971
Phenylalanine and tyrosine metabolism in Parkinson's disease treated with levodopaM H Van Woert
Progress in Clinical and Biological Research|January 1, 1985
Orphan Drug ActM H Van Woert
The New England Journal of Medicine|January 22, 1981
Orphan drugs: proposed legislative helpM H Van Woert
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1970
Effect of phenothiazines on melanoma tyrosinase activityM H Van Woert
Progress in Clinical and Biological Research|January 1, 1985
Problems associated with developing orphan drugs into available therapyM H Van Woert
Connecticut Medicine|June 1, 1970
Pharmacodynamics of 3, 4-dihydroxyphenylalanine (Dopa) in Parkinson's diseaseM H Van Woert
The New England Journal of Medicine|July 10, 1980
Drugs of limited commercial valueM H Van Woert
Progress in Clinical and Biological Research|January 1, 1983
Myoclonus and L-5-hydroxytryptophan (L-5HTP)M H Van Woert
JAMA|February 28, 1972
Low pyridoxine diet in parkinsonismM H Van Woert
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
The New England Journal of Medicine|April 20, 1978
Profitable and nonprofitable drugsM H Van Woert
Clinical Pharmacology and Therapeutics|March 1, 1971
Phenylalanine and tyrosine metabolism in Parkinson's disease treated with levodopaM H Van Woert
Progress in Clinical and Biological Research|January 1, 1985
Orphan Drug ActM H Van Woert
The New England Journal of Medicine|January 22, 1981
Orphan drugs: proposed legislative helpM H Van Woert
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1970
Effect of phenothiazines on melanoma tyrosinase activityM H Van Woert
Progress in Clinical and Biological Research|January 1, 1985
Problems associated with developing orphan drugs into available therapyM H Van Woert
Connecticut Medicine|June 1, 1970
Pharmacodynamics of 3, 4-dihydroxyphenylalanine (Dopa) in Parkinson's diseaseM H Van Woert
The New England Journal of Medicine|July 10, 1980
Drugs of limited commercial valueM H Van Woert
Progress in Clinical and Biological Research|January 1, 1983
Myoclonus and L-5-hydroxytryptophan (L-5HTP)M H Van Woert
JAMA|February 28, 1972
Low pyridoxine diet in parkinsonismM H Van Woert
Pageof 10